SWAV potential buy setupReasons for bullish bias: - Price gave weekly resistance breakout - No divergence - Bullish trend Here are the recommended trading levels: Entry Level(Buy limit): 299.32 Stop Loss Level: 244.90 Take Profit Level 1: 353.74 Take Profit Level 2: OpenLongby TradeWithParas1
J&J in Talks to Buy Shockwave MedicalJohnson & Johnson (J&J) is reportedly in advanced discussions to acquire Shockwave Medical ( NASDAQ:SWAV ), a leading player in the realm of cardiovascular devices. This strategic maneuver by the healthcare behemoth signifies a bold step towards expanding its foothold in the burgeoning cardiovascular market. According to reports from the Wall Street Journal, the talks between J&J and Shockwave Medical ( NASDAQ:SWAV ) are progressing steadily, with a deal on the horizon that could reshape the landscape of medical technology. With Shockwave Medical boasting a market capitalization of approximately $11 billion, the potential acquisition holds significant implications for both companies and the broader healthcare sector. The allure of Shockwave Medical ( NASDAQ:SWAV ) lies in its innovative approach to treating heart disease through cutting-edge devices designed to disrupt calcified plaque in heart vessels using shockwaves—a technique reminiscent of how kidney stones are traditionally addressed. This groundbreaking technology represents a paradigm shift in cardiovascular intervention, offering patients and healthcare providers a non-invasive alternative to conventional treatments. For J&J, a successful acquisition of Shockwave Medical would not only bolster its existing portfolio of cardiovascular products but also position the company at the forefront of medical innovation. With cardiovascular diseases posing a significant global health burden, estimated to affect millions of individuals worldwide, the demand for advanced therapeutic solutions continues to escalate. By harnessing the expertise of Shockwave Medical, J&J stands poised to address this pressing need and drive positive outcomes for patients around the globe. While details of the potential deal remain undisclosed, industry insiders speculate that a finalized agreement could materialize in the coming weeks, pending successful negotiations. However, amidst the excitement surrounding the prospective acquisition, it is worth noting that talks are subject to change, and alternative suitors may emerge, adding an element of uncertainty to the proceedings. In response to inquiries regarding the acquisition talks, J&J refrained from providing comment, maintaining a discreet stance on the matter. Similarly, Shockwave Medical opted not to engage in speculation, adhering to its policy of refraining from commenting on rumors or conjecture. News of the impending acquisition sent shockwaves through the market, driving a notable 11% surge in Shockwave Medical's stock price during afternoon trading—a testament to the market's confidence in the potential synergies and value creation opportunities associated with the proposed union. Against the backdrop of J&J's recent acquisition of heart pump maker Abiomed for a staggering $16.6 billion in 2022, the potential acquisition of Shockwave Medical ( NASDAQ:SWAV ) underscores the company's commitment to driving growth and innovation in the cardiovascular space. As the healthcare landscape continues to evolve, fueled by advancements in technology and a relentless pursuit of better patient outcomes, the proposed acquisition of Shockwave Medical by J&J stands poised to redefine the future of cardiovascular care, ushering in a new era of medical excellence and innovation.Longby DEXWireNews2
SWAV, 2/26-3/20, profit 11%On 2/15/2024, Shockwave Medical (SWAV) reported earnings of $1.16 per share on revenue of $202.98 million for the fourth quarter ended December 2023. The consensus earnings estimate was $0.92 per share on revenue of $199.45 million. Longby 1hour_trading0
$SWAV Pullback SetupNASDAQ:SWAV is a potential low risk pullback back in the handle of a large 27 week cup with handle base (zoom out to weekly chart). Very interesting setup as bulls attempt to close on a good note for the week.Longby TaPlot3
$SWAV Setting UpNASDAQ:SWAV for early next week looks like it wants to go. Some #AI and related tech stocks are very extended so potentially money rotating back into other growth areas.Longby TaPlot1
Roadmap for SWAVBlue solid lines are established downtrends, green dotted lines are established uptrends. Both the uptrend and downtrend lines are established from equilibrium points, (not highs and lows). Thickness of lines illustrates strength of previous price action. Circles are the crossing of uptrend and downtrend (Crossfire Points), usually resulting in reactions. by CrossfireTA1
SWAV - Over $300 pivot + Century Level Cup and HandleGreat combo of fundumentals and technicals. LONG SWINGLongby SwingDaddy693
Bearish $SWAV (Shockwave Medical) Rejected at the supply zone with an ominous inverted hammer + hanging man daily candle combo. Due for a pull-back. This massive cup needs to form a handle. Note the downside gap which would serve as an excellent handle target. Shortby EquityCast0
Channel Down Price is trying to break channel resistance line but has failed to do so today. Price is above the 50% mark and below the .382. No rising wedges noted in this chart and could have been a case of overvaluation causing the fall. Earnings 2-16 AMC. Short interest is around 3.3%. No recommendationby lauralea2
RectangleDescending triangle forming. Neutral until broken. Price is just below the .236 of the trend up. No recommendation/short with break of bottom support line. Price is trying to break upper support line today. Short interest is around 3.5%by lauraleaUpdated 0
$SWAV short idealooking for the final leg in this name. XLV + ES going down should also support this When (and if) price gets there, time for a rebound. The red line is the stop loss.Shortby PurpleGoat0
RectangleSmall gap below price and is providing support today. Price is just below the .236 of the trend up. No recommendation. Short interest is around 4%.by lauralea220
$SWAV - out for break-evenSome notes that made SWAV a lower prob setup. The big drops near and below the 50SMA, took quite a long time to gain back. This is a sign that it is not institutional buying supporting the wedge and breakout.Longby TintinTrading2
$SWAV - Buying now- Strong sector and industry - Good consolidation - Volume signature is mostly bullishLongby TintinTrading1
$SWAV setting back upThis potential leader held up better than many and now putting in a tend line breakout setup heading into the rest of this week.Longby TaPlot6
Symmetrical TriangleTriangles are neutral patterns until broken. Price has been struggling at the descending trendline of the triangle for a few days now. I am watching this one closely. A symmetrical triangle is a chart pattern characterized by two converging trend lines connecting a series of sequential peaks and troughs. These trend lines should be converging at a roughly equal slope. A spinning top at a level of support or a level of resistance can mean a change in trend even if just temporary. This is also ABC Bullish and C is at the spinning top. Strong support noted at C. Price is above the .236 of the trend up. Very small red volume bar compared to move up so far today. Volatile stock and can be a good reason to watch how a security moves before longing or shorting it. OBV is high. No recommendation. Don't be afraid of not knowing. You will eventually find out (o: by lauraleaUpdated 1
$SWAV Setting Upclam day today will set this up for a breakout later this week or early next week. Top watch stock.Longby TaPlot1
CrabBearish Crab. The 4th leg of the crooked W appears to have terminated at the 1.618. The Crab is a reversal pattern which causes price exhaustion. It is also an Extension pattern as the 4th leg ends above X. There is a gap below price that may or may not provide support. PE ratio is high, especially for this sector. There is no dividend so I am wondering why someone would hold on to this right now. But they might. Price is just above the .236 of the trend up No recommendation EPS (FWD) 2.73 PE (FWD) 92.39 Div Rate (TTM) - Yield (TTM) - Short Interest 5.26% Market Cap $9.06B ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Shortby lauralea0
$SWAV Consolidating with a Pivot$SWAV 3 week consolidation putting in a pivot to trade against.Longby TaPlot4
2 Potential Buys on SWAV$SWAV setting up a very nice 3 touch trendline here. Potentially setting up a mini coil as well if Monday's session can stay inside Thursdays bar Also watching this for a first touch of the 10 week line, but that will likely be market dependent by Amphibiantrading3
SWAV looks really goodFundamentally really good company breaking down trend line in a strong sector. Options chain is pretty trash on it but can be a shares play. Longby savage_Trader0
7/4/22 SWAVShockWave Medical, Inc. ( NASDAQ:SWAV ) Sector: Health Technology (Medical Specialties) Market Capitalization: $7.109B Current Price: $198.62 Breakout price: $200.15 Buy Zone (Top/Bottom Range): $194.30-$180.50 Price Target: $217.20-$221.90 (1st), $246.50-$249.80 (2nd) Estimated Duration to Target: 38-40d (1st), 83-88d (2nd) Contract of Interest: $SWAV 8/19/22 195c, $SWAV 10/21/22 195c Trade price as of publish date: $19.10/contract, $26.50/contractLongby lord_catnip1